ArticleInternational journal of surgery (London, England)2026

MLH1 deficiency in renal cell carcinoma: a promising yet challenging biomarker for immunotherapy.

Zhiyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.